| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3370516 | Journal of Clinical Virology | 2006 | 7 Pages |
Abstract
Taking into account the mutations associated with a better VR may improve genotypic resistance algorithms. Our results are of interest for the management of antiretroviral therapy in NRTI-experienced patients.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Sophie Capdepont, Valérie Aurillac-Lavignolle, Muriel Faure, Michel Dupon, Philippe Morlat, Jean-Marie Ragnaud, Geneviève Chêne, Hervé Fleury, Bernard Masquelier, GECSA GECSA,